Affiliations and Insurances

We accept most insurances. Also, our oncologist  has admitting privileges at hospitals throughout the Valley. To find out further information about a hospital, select the link below.

St. Rose Dominican Hospital Siena Campus
3001 St. Rose Parkway
Henderson, NV 89113
702-616-5000
Website | Phone Directory | Map To Hospital

St.Rose Dominican Hospitals de Lima Campus
102 E. Lake Mead Parkway
Henderson, NV 8015
702.616.5000
Website | Phone Directory | Map To Hospital

St.Rose Dominican Hospitals San Martin Campus
8280 W. Warm Springs Rd.
Las Vegas, NV 89113
702-492-8700
Website | Phone Directory | Map To Hospital

Southern Hills Hospital
9300 W. Sunset Rd.
Las Vegas, NV 89148
702-880-2100
Website | Phone Directory | Map To Hospital

Spring Valley Hospital
5400 S. Rainbow Blvd.
Las Vegas, NV 89118
702-853-3000
Website | Phone Directory | Map To Hospital

Summerlin Hospital
657 N. Town Center Drive
Las Vegas, NV 89144
702-233-7000
Website | Phone Directory | Map To Hospital

slide_0

NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award

09/06/17

Dr. Douglas R. Lowy and Dr. John T. Schiller of the National Cancer Institute receive the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the development of HPV vaccines. …read more Source:: Cancer


New Analysis Confirms Suspected Bias of Large U.S. Prostate Screening Study

09/05/17

By David Sampson A new paper appearing in Annals of Internal Medicine used simulation modeling to try to correct for a known bias in a notable U.S. trial of prostate cancer screening, called PLCO. That study along with a large … Read More


NCI study identifies essential genes for cancer immunotherapy

08/07/17

A new NCI study identifies genes in cancer cells that are necessary for them to be killed by T cells, and therefore could be partially responsible for why immunotherapy doesn’t work in some patients. …read more Source:: Cancer


NCI study shows feasibility of cancer screening protocol for patients with Li-Fraumeni syndrome

08/03/17

A new NCI study demonstrates the feasibility of a comprehensive screening protocol for patients with Li-Fraumeni syndrome, a rare inherited disorder that leads to a higher risk of developing certain cancers. …read more Source:: Cancer


NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers

07/24/17

The nationwide precision medicine trial will enroll children and adolescents with advanced cancers that haven’t responded to standard therapy to explore treatments targeted at specific genetic mutations. …read more Source:: Cancer


TCGA study of liver cancer reveals potential targets for therapy

06/15/17

Only two drugs are FDA-approved for liver cancer. This study of hepatocellular carcinoma found genetic alterations in tumors—including mutations in tumor-suppressing genes and high expression of immune checkpoint genes—that could be targets for drugs that already exist. …read more Source:: … Read More


Don’t Fry Day: Getting Sunscreen Right

05/25/17

By David Sampson Despite increased awareness about the dangers of ultraviolet (UV) radiation, melanoma rates continue to rise in the United States. For “Don’t Fry Day” on May 26, the American Cancer Society is cautioning that many people may be … Read More


Ventilated Filters: Changing the Face of Lung Cancer in the U.S.

05/23/17

By David Sampson An analysis appearing in the Journal of the National Cancer Institute finds strong evidence that adding ventilation holes to cigarette filters has contributed to a rise in a type of lung cancer called adenocarcinoma among smokers. The … Read More


Study estimates number of U.S. women living with metastatic breast cancer

05/18/17

A new study shows that the number of women in the United States living with distant metastatic breast cancer (MBC), the most severe form of the disease, is growing. This is likely due to the aging of the U.S. population … Read More


14: The Unmentioned Number in the Prostate Cancer/Coffee Story

05/05/17

By David Sampson Headlines across the Internet blared with the news over the past week that coffee could cut the risk of prostate cancer in half. It was an irresistible headline. But just how reliable was the finding? What if … Read More